ArticleJournal of cellular and molecular medicine2020

Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy.

Mingjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.